Aflac Just Extended Its Dividend Growth Streak to 44 Years. Is It a Buy?

Impact · against what's priced in

Aflac's fourth consecutive earnings miss and widening unrealized losses in Japan challenge the market's assumption of a revenue recovery, though its dividend safety is well-supported. MetLife and Prudential remain largely unchanged as the article merely confirms previously priced-in strengths and weaknesses.

AFL−0.40

Challenges what's priced in

The price assumes

Japan revenue recovery and accelerated contract sales growth